This Vaccine Reduces Risk of Melanoma Coming Back. Can It Work for Other Cancers?
7 Articles
7 Articles
The Union Democrat
This vaccine reduces risk of melanoma coming back. Can it work for other cancers?
Intismeran Autogene, a vaccine that treats melanoma, a deadly type of skin cancer, has made headlines worldwide. Recently reported results indicate that the personalized medication, taken in combination with the immunotherapy Keytruda, met its main goal, reducing the chances of…
Christinareal companies Advances in melanoma MSD and Moderna have achieved something that the cancer industry has been pursuing for years: to demonstrate, according to the preliminary results reported by both companies, that a personalized therapy based on messenger RNA can improve the results of an already consolidated immunotherapy. The success of INTerpath-001, the pivotal trial of intismeran autogene -before V940 or mRNA-4157- in high-risk r…
Moderna may finally hold the product capable of turning the Covid-19 page. With Merck, the American laboratory has just announced positive results in phase 3 for personalized messenger RNA therapy aimed at reducing the risk of relapse in patients with melanoma. A first for this technology, but certainly not yet a definitive victory against cancer.
The new vaccine was administered to patients with high-risk melanoma.
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
